Loading
Respiratory Viral Infections Research / Pneumonia and Respiratory Infections · Journal article
Acta Microbiologica Hellenica · September 9, 2026
A consensus or society position rather than new primary data.
This is an expert consensus report on the diagnostic and epidemiological challenges of pneumococcal disease in India, based on a non-systematic literature review and panel discussion rather than primary research. The panelists identify multiplex real-time PCR and BioFire FilmArray as common diagnostic methods in tier 1 Indian cities and call for better diagnostic capacity and public health partnership to determine true disease burden, but report no new data on diagnostic performance, disease incidence, or intervention outcomes.
Expert panel discussion with non-systematic targeted literature review. Expert panelists from different parts of India; clinical focus on children < 5 years and adults > 50 years with invasive pneumococcal disease.. n = 12. India (different regions represented by panelists; specific locations not named).
Invasive pneumococcal disease associated with high mortality in children < 5 years and adults > 50 years in India Culture identified as gold standard; multiplex real-time PCR and BioFire FilmArray most common detection methods in tier 1 cities Diagnostic challenges in India hinder disease management and estimation of true pneumococcal disease burden
No epidemiological data on pneumococcal disease incidence, prevalence, or mortality in India Invasive pneumococcal disease associated with high mortality in children < 5 years and adults > 50 years in India
This report highlights that diagnostic barriers in India prevent accurate assessment of pneumococcal disease burden and may impede appropriate vaccination policy. Clinicians should recognize that reported disease figures may underestimate true incidence, and should advocate for improved diagnostic capacity and epidemiological surveillance infrastructure.
An expert panel discussion synthesizing clinical and microbiological perspectives on diagnostic approaches and disease burden assessment, without original empirical data or trials.
As stated by the source record.
This report highlights that diagnostic barriers in India prevent accurate assessment of pneumococcal disease burden and may impede appropriate vaccination policy. Clinicians should recognize that reported disease figures may underestimate true incidence, and should advocate for improved diagnostic capacity and epidemiological surveillance infrastructure.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Background: Invasive pneumococcal disease (IPD) is predominantly caused by Streptococcus pneumoniae and is associated with high mortality. This vaccine-preventable disease has been a significant public health concern, particularly among children < 5 years and adults > 50 years in India. Pneumococcal vaccines help prevent pneumococcal infections caused by certain strains of S. pneumoniae, but diagnostic challenges in India hinder disease management. Methods: The objective of this expert panel discussion is to deliberate upon the pathogenesis and epidemiology of S. pneumoniae in India, techniques for overcoming the diagnostic challenges in the isolation and detection of S. pneumoniae, and to explore opportunities for partnerships between clinicians and microbiologists to bridge gaps. A non-systematic, targeted literature search was conducted to identify studies supporting key themes of expert panel discussion. Eight microbiologists, one infectious disease, one pediatrics and neonatology, and one respiratory medicine specialist from different parts of India participated in the discussion. Results: The panelists reiterated that while culture is the gold standard, multiplex real-time polymerase chain reaction and BioFire® FilmArray® technology have been the most common diagnostic methods for the detection of S. pneumoniae in India, especially in tier 1 cities. Conclusions: This article elucidates the challenges faced by microbiologists and clinicians in isolating and detecting the pathogen, and proposes solutions to determine the true burden of pneumococcal disease in India. This information could further inform public health policy and vaccination strategies.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.